|
Lazaro Sanchez AD, Benitez Fuentes JD, Gil GL, Garcia MTG, Moreno EF, Zamora PC, Yago JB, Mohamed KM, Arroyo Rodriguez AB. Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report. J Clin Med. 2025 Feb 17;14(4):1333. doi: 10.3390/jcm14041333. PubMed PMID: 40004863; PubMed Central PMCID: PMC11856639.
AÑO: 2025; IF: 3.0
|
40004863
|
Feliciangeli E, Albaladejo-Gonzalez A, Garcia-Rodriguez J, Lazaro-Sanchez A, Borg R, Pimentel-Caceres P, Soriano-Polo D, Rodriguez-Braun E, Balsalobre-Yago J, Martinez-Ortiz MJ, Wikstrom-Fernandez S, Murillo-Herrera A, Garcia-Garcia T, Garcia-Solano J, Conesa-Zamora P, Luengo-Gil G. Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Sci Rep. 2025 Jul 1;15(1):21626. doi: 10.1038/s41598-025-04962-w. PubMed PMID: 40594059.
AÑO: 2025; IF: 3.8
|
|
Provencio M, Rodriguez-Abreu D, Ortega AL, Serrano G, Aguado C, Franco F, Gutierrez V, Lopez Vivanco G, Guirado M, Benitez G, Estival A, Calvo V, Jimenez B, Arasanz H, Coves J, Majem M, Massuti B, Vazquez S, Juan-Vidal O, Collazo-Lorduy A, Gozalvez CL, Del Barco E, Rosero A, Bosch-Barrerra J, Moreno MA, Mielgo-Rubio X, Villa JC, Lopez-Martin A, Cordoba JF, de Asis Aparisi F, Zafra M, Mosquera J, Perez Altozano J, Nadal E, Catot S, Balsalobre J, de Portugal T, Martin P, Cuesta de Juan S, Cobo M. Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study. Transl Lung Cancer Res. 2022 Jan;11(1):53-63. doi: 10.21037/tlcr-21-504. PubMed PMID: 35242627; PubMed Central PMCID: PMC8825652.
AÑO: 2022; IF: 4.0
|
|
Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglyte M, Sanchez-Hernandez A, de Julian Campayo M, Garcia-Giron C, Domine M, Blasco A, Sanchez JM, Oramas J, Bosch-Barrera J, Sala MA, Sereno M, Ortega AL, Chara L, Hernandez B, Padilla A, Coves J, Blanco R, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila MA, Romero A. Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment. Eur J Cancer. 2021 May;149:61-72. doi: 10.1016/j.ejca.2021.02.031. Epub 2021 Apr 5. PubMed PMID: 33831609.
AÑO: 2021; IF: 8.4
|